<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37058056</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>14</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Systemic lupus erythematosus complicated with cryptococcal meningitis: A case report.</ArticleTitle><Pagination><StartPage>e33541</StartPage><MedlinePgn>e33541</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e33541</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000033541</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Patients with systemic lupus erythematosus (SLE) complicated with cryptococcal meningitis (CM) are easy to be misdiagnosed as neuropsychiatric lupus or tuberculous meningitis due to the lack of specificity of clinical symptoms, which may delay treatment. Through this case, we considered early improvement of India ink stain of cerebrospinal fluid (CSF) and metagenomic next generation sequences to determine whether there is microbial infection, and gave the idea of empirical anti-infection therapy, so as to make early diagnosis and slow down the progression of the disease.</AbstractText><AbstractText Label="PATIENT CONCERNS" NlmCategory="METHODS">We report the case of a 40-year-old female with SLE for 10 years. Five days ago she came down with a fever and a headache.</AbstractText><AbstractText Label="DIAGNOSIS, INTERVENTIONS, AND OUTCOMES" NlmCategory="METHODS">India ink stain of CSF in patients with SLE shows Cryptococcus neoformans growth. Combined with imaging findings, the patient was diagnosed with CM. The patient improved after 3 weeks of antifungal therapy with amphotericin B 42&#x2009;mg/d and flucytosine 6000&#x2009;mg/d.</AbstractText><AbstractText Label="LESSONS" NlmCategory="CONCLUSIONS">The possibility of CM should be considered when SLE patients have sudden headache and fever. India ink stain of CSF and metagenomic next generation sequences should be actively improved in the early stage of the disease to identify whether there is microbial infection, and early empirical anti-infection treatment should be given to reduce mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Honglei</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7104-8357</Identifier><AffiliationInfo><Affiliation>Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuqun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Junhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Linping</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Affiliated Hospital of Weifang Medical University, Weifang, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yingliang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Affiliated Hospital of Weifang Medical University, Weifang, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C028433">chinese ink</NameOfSubstance></Chemical><Chemical><RegistryNumber>7XU7A7DROE</RegistryNumber><NameOfSubstance UI="D000666">Amphotericin B</NameOfSubstance></Chemical><Chemical><RegistryNumber>D83282DT06</RegistryNumber><NameOfSubstance UI="D005437">Flucytosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016919" MajorTopicYN="Y">Meningitis, Cryptococcal</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000666" MajorTopicYN="N">Amphotericin B</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005437" MajorTopicYN="N">Flucytosine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000935" MajorTopicYN="N">Antifungal Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003455" MajorTopicYN="Y">Cryptococcus neoformans</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37058056</ArticleId><ArticleId IdType="pmc">PMC10101247</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000033541</ArticleId><ArticleId IdType="pii">00005792-202304140-00046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Broadway-Duren JB, Cesario SK. A systematic review of the literature on systemic lupus erythematosus. J Natl Black Nurses Assoc. 2020;31:60&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33617709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384:1878&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">24881804</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol. 2020;16:527&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">32478627</ArticleId></ArticleIdList></Reference><Reference><Citation>Tristano AG. Criptococosis men&#xed;ngea y lupus eritematoso sist&#xe9;mico: reporte de un caso y revisi&#xf3;n de la literatura [Cryptococcal meningitis and systemic lupus erythematosus: a case report and review]. Rev Chilena Infectol. 2010;27:155&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20556320</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson PR, Nash TE, Williamson KC, et al. . CNS infections in 2015: emerging catastrophic infections and new insights into neuroimmunological host damage. Lancet Neurol. 2016;15:17&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5558091</ArticleId><ArticleId IdType="pubmed">26700901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyrgos V, Seitz AE, Steiner CA, et al. . Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS One. 2013;8:e56269e56269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3574138</ArticleId><ArticleId IdType="pubmed">23457543</ArticleId></ArticleIdList></Reference><Reference><Citation>Justiz Vaillant AA, Goyal A, Varacallo M. Systemic Lupus Erythematosus. StatPearls Publishing LLC; 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">30571026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiriakidou M, Cotton D, Taichman D, et al. . Systemic lupus erythematosus. Ann Intern Med. 2013;159:Itc4&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">24081299</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu TB, Perlin DS, Xue C. Molecular mechanisms of cryptococcal meningitis. Virulence. 2012;3:173&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3396696</ArticleId><ArticleId IdType="pubmed">22460646</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst C, Pongratz G, Capellino S, et al. . Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report. BMC Infect Dis. 2010;10:239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2931510</ArticleId><ArticleId IdType="pubmed">20699010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003;362:1828&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">14654323</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumura M, Kawamura R, Inoue R, et al. . Concurrent presentation of cryptococcal meningoencephalitis and systemic lupus erythematosus. Mod Rheumatol. 2011;21:305&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3110276</ArticleId><ArticleId IdType="pubmed">21188455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tattevin P, Tchamgou&#xe9; S, Belem A, et al. . Aseptic meningitis. Rev Neurol (Paris). 2019;175:475&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">31375286</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelehe-Okouma M, Czmil-Garon J, Pape E, et al. . Drug-induced aseptic meningitis: a mini-review. Fundam Clin Pharmacol. 2018;32:252&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">29364542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee RZ, Hardiman O, O&#x2019;Connell PG. Ibuprofen-induced aseptic meningoencephalitis. Rheumatology (Oxford). 2002;41:353&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11934981</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CY, Miller SA. Clinical metagenomics. Nat Rev Genet. 2019;20:341&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858796</ArticleId><ArticleId IdType="pubmed">30918369</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol. 2019;14:319&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6345613</ArticleId><ArticleId IdType="pubmed">30355154</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal JE, Gerhardt J, Peixoto de Miranda EJ, et al. . Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. Diagn Microbiol Infect Dis. 2012;73:68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3351690</ArticleId><ArticleId IdType="pubmed">22578940</ArticleId></ArticleIdList></Reference><Reference><Citation>Graybill JR, Sobel J, Saag M, et al. . Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis. 2000;30:47&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">10619732</ArticleId></ArticleIdList></Reference><Reference><Citation>Perfect JR, Dismukes WE, Dromer F, et al. . Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50:291&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5826644</ArticleId><ArticleId IdType="pubmed">20047480</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>